JUVENILE POLYMYOSITIS
Clinical trials for JUVENILE POLYMYOSITIS explained in plain language.
Never miss a new study
Get alerted when new JUVENILE POLYMYOSITIS trials appear
Sign up with your email to follow new studies for JUVENILE POLYMYOSITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
CAR T-Cell therapy takes on rare muscle disease
Disease control Recruiting nowThis study tests a new treatment called CABA-201 for people with active idiopathic inflammatory myopathy, a group of rare diseases that cause muscle inflammation and weakness. The treatment uses a patient's own immune cells, modified to target and destroy faulty B cells. The goal…
Matched conditions: JUVENILE POLYMYOSITIS
Phase: PHASE2, PHASE3 • Sponsor: Cabaletta Bio • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Could your environment trigger a rare muscle disease?
Knowledge-focused Recruiting nowThis study looks at whether certain environmental exposures—like infections, stress, or sun exposure—are more common in people with anti-synthetase syndrome (a type of myositis with lung involvement) compared to other myositis patients and healthy volunteers. Researchers will col…
Matched conditions: JUVENILE POLYMYOSITIS
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC